| A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ... Alzheimer's & dementia 10 (6), 844-852, 2014 | 2461 | 2014 |
| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 2160 | 2013 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1104 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 990 | 2011 |
| The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of … KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ... International psychogeriatrics 21 (4), 672-687, 2009 | 851 | 2009 |
| Implementation of subjective cognitive decline criteria in research studies JL Molinuevo, LA Rabin, R Amariglio, R Buckley, B Dubois, KA Ellis, ... Alzheimer's & Dementia 13 (3), 296-311, 2017 | 471 | 2017 |
| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 455 | 2012 |
| Increased risk of cognitive impairment in patients with diabetes is associated with metformin EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ... Diabetes care 36 (10), 2981-2987, 2013 | 450 | 2013 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 447 | 2010 |
| Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ... Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015 | 431 | 2015 |
| Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ... Translational psychiatry 3 (2), e233-e233, 2013 | 310 | 2013 |
| Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective … VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... Lancet Neurol 12 (4), 357-367, 2013 | 287 | 2013 |
| Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ... Brain 135 (7), 2126-2139, 2012 | 286 | 2012 |
| Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations PA Yates, VL Villemagne, KA Ellis, PM Desmond, CL Masters, CC Rowe Frontiers in neurology 4, 205, 2014 | 272 | 2014 |
| Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ... Molecular psychiatry 18 (8), 875-881, 2013 | 259 | 2013 |
| β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ... Neurology 74 (2), 121-127, 2010 | 257 | 2010 |
| Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ... Annals of neurology 74 (6), 905-913, 2013 | 244 | 2013 |
| Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease YY Lim, P Maruff, RH Pietrzak, D Ames, KA Ellis, K Harrington, ... Brain 137 (1), 221-231, 2014 | 229 | 2014 |
| Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study RH Pietrzak, YY Lim, A Neumeister, D Ames, KA Ellis, K Harrington, ... JAMA psychiatry 72 (3), 284-291, 2015 | 211 | 2015 |
| Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ... JAMA neurology 70 (7), 903-911, 2013 | 206 | 2013 |
